Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22(1):76–98.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, et al. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127(20):2427–38.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)–seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002;185(3):273–82.

PubMed  Article  PubMed Central  Google Scholar 

Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, et al. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biology of Blood and Marrow Transplantation. 2010;16(9):1309–14.

PubMed  Article  PubMed Central  Google Scholar 

Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood. 2004;103(6):2003–8.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Schmidt-Hieber M, Tridello G, Ljungman P, Mikulska M, Knelange N, Blaise D, et al. The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT. Ann Hematol. 2019;98(7):1755–63.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Kollman C, Howe CWS, Anasetti C, Antin JH, Davies SM, Filipovich AH, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98(7):2043–51.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood. 2003;102(13):4255–60.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Ljungman P, Brand R, Hoek J, Camara RDL, Cordonnier C, Einsele H, et al. Donor Cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European Group for Blood and Marrow Transplantation. Clin Infect Dis. 2014;59(4):473–81.

PubMed  Article  PubMed Central  Google Scholar 

Broers AEC, Holt RVD, Esser JWJV, Gratama J-W, Henzen-Logmans S, Kuenen-Boumeester V, et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation. Blood. 2000;95(7):2240–5.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Einsele H, Hebart H, Kauffmann-Schneider C, Sinzger C, Jahn G, Bader P, et al. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant. 2000;25(7):757–63.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Meijer E, Dekker AW, Verdonck LF. Influence of antithymocyte globulin dose on outcome in cytomegalovirus-seropositive recipients of partially T cell-depleted stem cell grafts from matched-unrelated donors. Br J Haematol. 2003;121(3):473–6.

PubMed  Article  PubMed Central  Google Scholar 

Junghanss C, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood. 2002;99(6):1978–85.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Nakamae H, Kirby KA, Sandmaier BM, Norasetthada L, Maloney DG, Maris MB, et al. Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation. 2009;15(6):694–703.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Melendez-Munoz R, Marchalik R, Jerussi T, Dimitrova D, Nussenblatt V, Beri A, et al. Cytomegalovirus infection incidence and risk factors across diverse hematopoietic cell transplantation platforms using a standardized monitoring and treatment approach: a comprehensive evaluation from a single institution. Biology of Blood and Marrow Transplantation. 2019;25(3):577–86.

PubMed  Article  PubMed Central  Google Scholar 

Ljungman P, Perez-Bercoff L, Jonsson J, et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica. 2006;91:78.

PubMed  PubMed Central  Google Scholar 

Mcgoldrick SM, Bleakley ME, Guerrero A, Turtle CJ, Yamamoto TN, Pereira SE, et al. Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo. Blood. 2013;121(14):2796–803.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Parody R, Martino R, Rovira M, Vazquez L, Vázquez MJ, Cámara RDL, et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biology of Blood and Marrow Transplantation. 2006;12(7):734–48.

PubMed  Article  PubMed Central  Google Scholar 

Albano MS, Taylor P, Pass RF, Scaradavou A, Ciubotariu R, Carrier C, et al. Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening. Blood. 2006;108(13):4275–82.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Walker CM, Burik J-AHV, For TED, Weisdorf DJ. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biology of Blood and Marrow Transplantation. 2007;13(9):1106–15.

PubMed  Article  PubMed Central  Google Scholar 

Natori Y, Alghamdi A, Tazari M, Miller V, Husain S, Komatsu T, et al. Humar A; CMV Consensus Forum. Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis. Clin Infect Dis. 2018;66(4):617–31.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant. 2009;9(2):258–68.

PubMed  Article  CAS  PubMed Central  Google Scholar 

Freyer JF, Heath AB, Anderson R Minor PD; Collaborative Study Group. Collaborative study to evaluate the proposed First WHO International Standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays. WHO ECBS report 2010: WHO/BS/10.2138. Available at: whqlibdoc.who.int/hq/2010/WHO_BS_10.2138_eng.pdf

Hayden RT, Sun Y, Tang L, Procop GW, Hillyard DR, Pinsky BA, et al. Progress in quantitative viral load testing: variability and impact of the WHO Quantitative International Standards. J Clin Microbiol. 2017;55(2):423–30.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Preiksaitis JK, Hayden RT, Tong Y, Pang XL, Fryer JF, Heath AB, et al. Are we there yet? Impact of the first international standard for cytomegalovirus DNA on the harmonization of results reported on plasma samples. Clin Infect Dis. 2016;63:583–9.

PubMed  Article  PubMed Central  Google Scholar 

Piñana JL, Giménez E, Gómez MD, Pérez A, González EM, Vinuesa V, et al. Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: implications for the diagnosis of CMV pneumonia. J Infect. 2019;78(5):393–401.

PubMed  PubMed Central  Article  Google Scholar 

Boeckh M, Stevens-Ayers T, Travi G, Huang M-L, Cheng G-S, Xie H, et al. Cytomegalovirus (CMV) DNA quantitation in bronchoalveolar lavage fluid from hematopoietic stem cell transplant recipients with CMV pneumonia. J Infect Dis. 2017;215(10):1514–22.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tan SK, Burgener EB, Waggoner JJ, Gajurel K, Gonzalez S, Chen SF, et al. Molecular and culture-based bronchoalveolar lavage fluid testing for the diagnosis of cytomegalovirus pneumonitis. Open Forum Infectious Diseases. 2015;3(1).

Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64:87–91.

PubMed  Article  PubMed Central  Google Scholar 

Suárez-Lledó M, Marcos MÁ, Cuatrecasas M, Bombi JA, Fernández-Avilés F, Magnano L, et al. Quantitative PCR is faster, more objective, and more reliable than immunohistochemistry for the diagnosis of cytomegalovirus gastrointestinal disease in allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation. 2019;25(11):2281–6.

PubMed  Article  CAS  PubMed Central  Google Scholar 

JMM G, Van Der Gun BTF, Schmolke S, MVD G, WJV S, Plachter B, et al. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol. 1992;73(11):2923–32.

Article  Google Scholar 

Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol. 2002;40(3):746–52.

PubMed  PubMed Central  Article  Google Scholar 

Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets. 2011;11(5):466–74.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Razonable RR, Inoue N, Pinninti SG, Boppana SB, Lazzarotto T, Gabrielli L, et al. Clinical diagnostic testing for human cytomegalovirus infection